Results 301 to 307 of about 288,159 (307)

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors against clinical isolates of the influenza viruses circulating in the 2010–2011 to 2014–2015 Japanese influenza seasons

Journal of Infection and Chemotherapy, 2016
Hideyuki Ikematsu, Naoki Kawai, Norio Iwaki   +2 more
exaly  

The power issue: determination of KB or Ki from IC50

Journal of Pharmacological and Toxicological Methods, 2001
openaire   +1 more source

Single concentration loss of activity assay provides an improved assessment of drug–drug interaction risk compared to IC50-shift

Xenobiotica, 2016
exaly  

The effect of electronegative substituents on “IC50 value”

2017
ÇOLAK, Özlem, ARSLAN, Fatma, SARI, Nurşen, HASANOĞLU ÖZKAN, Elvan, ÇAT, Meryem   +4 more
openaire   +1 more source

Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50shift approach facilitateskinactassay design

Xenobiotica, 2009
exaly  

Some Tribological Aspects of the IC50 Ordered Alloy

1995
Straffelini, Giovanni, R. Dorigatti, Gialanella, Stefano, Molinari, Alberto   +3 more
openaire   +1 more source

Parameters used to evaluate the antioxidant capacity (inhibition, MRI, and IC50)

openaire   +1 more source